103 related articles for article (PubMed ID: 2242792)
1. Levels of soluble interleukin-2 receptors correlate with the severity of atopic dermatitis.
Wüthrich B; Joller-Jemelka H; Helfenstein U; Grob PJ
Dermatologica; 1990; 181(2):92-7. PubMed ID: 2242792
[TBL] [Abstract][Full Text] [Related]
2. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis.
Kägi MK; Joller-Jemelka H; Wüthrich B
Dermatology; 1992; 185(2):88-92. PubMed ID: 1421636
[TBL] [Abstract][Full Text] [Related]
3. [The study of immunological markers in patients with "intrinsic" type atopic dermatitis].
Yamashiro M; Okubo Y; Kato Y; Tamaki T; Koga M
Arerugi; 2002 Jul; 51(7):552-8. PubMed ID: 12201168
[TBL] [Abstract][Full Text] [Related]
4. Production of interleukin-2 by mononuclear cells in vitro in patients with atopic dermatitis and psoriasis. Comparison with serum interleukin-2 receptor levels.
Kapp A; Neuner P; Krutmann J; Luger TA; Schöpf E
Acta Derm Venereol; 1991; 71(5):403-6. PubMed ID: 1684468
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of serologic immune parameters in inflammatory skin diseases.
Gebhardt M; Wenzel HC; Hipler UC; Herrmann D; Wollina U
Allergy; 1997 Nov; 52(11):1087-94. PubMed ID: 9404560
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous CD30+ cells in children with atopic dermatitis.
Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R
Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.
Hanafusa T; Matsui S; Murota H; Tani M; Igawa K; Katayama I
Clin Exp Immunol; 2013 Jun; 172(3):507-12. PubMed ID: 23600840
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of the soluble interleukin-2 receptor in vitiligo patients.
Yeo UC; Yang YS; Park KB; Sung HT; Jung SY; Lee ES; Shin MH
J Dermatol Sci; 1999 Apr; 19(3):182-8. PubMed ID: 10215190
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis.
Wüthrich B; Kägi MK; Joller-Jemelka H
Arch Dermatol Res; 1992; 284(6):339-42. PubMed ID: 1284103
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in childhood.
Halmerbauer G; Frischer T; Koller DY
Allergy; 1997 Jul; 52(7):765-9. PubMed ID: 9265994
[TBL] [Abstract][Full Text] [Related]
11. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis.
Furue M; Sugiyama H; Tsukamoto K; Ohtake N; Tamaki K
J Dermatol Sci; 1994 Apr; 7(2):89-95. PubMed ID: 8060919
[TBL] [Abstract][Full Text] [Related]
12. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity.
Walker C; Kägi MK; Ingold P; Braun P; Blaser K; Bruijnzeel-Koomen CA; Wüthrich B
Clin Exp Allergy; 1993 Feb; 23(2):145-53. PubMed ID: 8448682
[TBL] [Abstract][Full Text] [Related]
13. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.
Kakinuma T; Nakamura K; Wakugawa M; Mitsui H; Tada Y; Saeki H; Torii H; Komine M; Asahina A; Tamaki K
Clin Exp Immunol; 2002 Feb; 127(2):270-3. PubMed ID: 11876749
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.
Suzuki H; Sugaya M; Nakajima R; Oka T; Takahashi N; Nakao M; Miyagaki T; Asano Y; Sato S
J Dermatol; 2018 Dec; 45(12):1440-1443. PubMed ID: 30289574
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble interleukin-2 receptor in eosinophilia.
Kaito K; Otsubo H; Ogasawara Y; Kimura H; Kurihara E; Koike M; Aiso M; Kobayashi M
Acta Haematol; 2003; 109(1):23-8. PubMed ID: 12486319
[TBL] [Abstract][Full Text] [Related]
16. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis.
Czech W; Krutmann J; Schöpf E; Kapp A
Br J Dermatol; 1992 Apr; 126(4):351-5. PubMed ID: 1571256
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of soluble intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and interleukin-2 receptor in patients with vernal keratoconjunctivitis and allergic conjunctivitis.
Uchio E; Ono S; Ikezawa Z; Ohno S
Allergy; 1999 Feb; 54(2):135-41. PubMed ID: 10221436
[TBL] [Abstract][Full Text] [Related]
18. Soluble interleukin-2 receptor serum levels in mycosis fungoides. Correlation with clinical stage.
Szeimies RM; Rueff F; Kaudewitz P
Cancer; 1992 Nov; 70(9):2338-41. PubMed ID: 1394062
[TBL] [Abstract][Full Text] [Related]
19. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokine levels in atopic dermatitis.
Yoshizawa Y; Nomaguchi H; Izaki S; Kitamura K
Clin Exp Dermatol; 2002 May; 27(3):225-9. PubMed ID: 12072014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
